AKT1 and sarcoma: In addition, it is reported that inhibiting AKT1/2 reduces NANOG expression in sarcoma CSC to reverse chemotherapy resistance [37], NANOG mediates the radio-resistance of tumor cells through AKT and Notch pathways partially [87].